AdvanCell’s Generator is a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy – the reliable and scalable supply of isotope. The manufacture of clinical doses of a high-value isotope Alpha 212® (Lead-212) for use in targeted radionuclides therapy is a game-changer for prostate and several other cancer treatments. Enabling scalable local isotope production capability, the Generator will fast track the delivery of cutting-edge cancer treatments to patients.
Vaulta has developed a patented combination of smart design and materials that creates a lighter, cheaper and thermally superior battery case, and eliminates the need for complex assembly. With no welding, cells can be reused and reconfigured as needed. Perfect for stationary storage projects, electric vehicles, niche products and more.